Acadia Pharma (ACAD) Misses Q1 EPS by 13c
Tweet
Share
E-mailGet Alerts ACAD Hot Sheet
Price: $28.38 --0%
Financial Fact:
Collaborative revenues: 5.27M
Today's EPS Names:
EGRX, MOVE, MDRX, More
Financial Fact:
Collaborative revenues: 5.27M
Today's EPS Names:
EGRX, MOVE, MDRX, More
Join SI Premium – FREE
Acadia Pharma (NASDAQ: ACAD) reported Q1 EPS of ($0.40), $0.13 worse than the analyst estimate of ($0.27). Revenue for the quarter came in at $4 thousand versus the consensus estimate of $80 thousand.
For earnings history and earnings-related data on Acadia Pharma (ACAD) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Nomura/Instinet Upgrades Genting Singapore (GENS:SP) (GIGNY) to Neutral
- Jernigan Capital (JCAP) Tops Q2 EPS by 5c
- Bio-key International, Inc. (BKYI) Tops Q2 EPS by 24c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
